Works matching IS 10837159 AND DT 2022 AND VI 27 AND IP 4

Results: 19

Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination.

Published in:

Oncologist, 2022, v. 27, n. 4, p. e357, doi. 10.1093/oncolo/oyac032

By:

Guven, Deniz C;
Sahin, Taha K;
Akın, Serkan;
Uckun, Fatih M

Publication type:

Article

Pembrolizumab and Trastuzumab in High Tumor Mutational Burden and POLE-Mutated HER2-Positive Refractory Breast Cancer.

Published in:

Oncologist, 2022, v. 27, n. 4, p. 245, doi. 10.1093/oncolo/oyac027

By:

Zhang, Li;
Chen, Yimeng;
Lv, Yao;
Jiao, Shunchang;
Zhao, Weihong

Publication type:

Article

Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors.

Published in:

Oncologist, 2022, v. 27, n. 4, p. e353, doi. 10.1093/oncolo/oyac026

By:

Mullenix, Cristina;
Ballman, Madison;
Chen, Haobin;
Swift, Shannon;
McAdams, Meredith J;
Tsai, Yo-Ting;
Donahue, Renee N;
Poretta, Trina;
Gupta, Sarthak;
Loehrer, Patrick J;
Schlom, Jeffrey;
Gulley, James L;
Rajan, Arun

Publication type:

Article

Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma.

Published in:

Oncologist, 2022, v. 27, n. 4, p. e340, doi. 10.1093/oncolo/oyac024

By:

Lin, Cheng;
Lin, Keyu;
Zhang, Bin;
Su, Ying;
Guo, Qiaojuan;
Lu, Tianzhu;
Xu, Yuanji;
Lin, Shaojun;
Zong, Jingfeng;
Pan, Jianji

Publication type:

Article

Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG).

Published in:

Oncologist, 2022, v. 27, n. 4, p. 255, doi. 10.1093/oncolo/oyac022

By:

Popat, Sanjay;
Hsia, Te-Chun;
Hung, Jen-Yu;
Jung, Hyun Ae;
Shih, Jin-Yuan;
Park, Cheol Kyu;
Lee, Seung Hyeun;
Okamoto, Tatsuro;
Ahn, Hee Kyung;
Lee, Yong Chul;
Sato, Yuki;
Lee, Sung Sook;
Mascaux, Celine;
Daoud, Hasan;
Märten, Angela;
Miura, Satoru

Publication type:

Article

Efficacy of Infliximab Dose Escalation in Patients with Refractory Immunotherapy-Related Colitis: A Case Series.

Published in:

Oncologist, 2022, v. 27, n. 4, p. e350, doi. 10.1093/oncolo/oyac019

By:

Harris, Jessica P;
Postow, Michael A;
Faleck, David M

Publication type:

Article

Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status.

Published in:

Oncologist, 2022, v. 27, n. 4, p. 307, doi. 10.1093/oncolo/oyac018

By:

Wood, Anthony C;
Zhang, Yonghong;
Mo, Qianxing;
Cen, Ling;
Fontaine, Jacques;
Hoffe, Sarah E;
Frakes, Jessica;
Dineen, Sean P;
Pimiento, Jose M;
Walko, Christine M;
Mehta, Rutika

Publication type:

Article

Surrogacy Beyond Prognosis: The Importance of "Trial-Level" Surrogacy.

Published in:

Oncologist, 2022, v. 27, n. 4, p. 266, doi. 10.1093/oncolo/oyac006

By:

Buyse, Marc;
Saad, Everardo D;
Burzykowski, Tomasz;
Regan, Meredith M;
Sweeney, Christopher S

Publication type:

Article

Impact of Iron-Deficiency Management on Quality of Life in Patients with Cancer: A Prospective Cohort Study (CAMARA Study).

Published in:

Oncologist, 2022, v. 27, n. 4, p. 328, doi. 10.1093/oncolo/oyac005

By:

Gluszak, Cassandre;
Vries-Brilland, Manon de;
Seegers, Valérie;
Baroin, Céline;
Kieffer, Helene;
Delva, Remy;
Cornuault-Foubert, Delphine

Publication type:

Article

Genetic Evaluation for Hereditary Cancer Syndromes Among African Americans: A Critical Review.

Published in:

Oncologist, 2022, v. 27, n. 4, p. 285, doi. 10.1093/oncolo/oyab082

By:

Khan, Ambreen;
Rogers, Charles R;
Kennedy, Carson D;
Lopez, AnaMaria;
Jeter, Joanne

Publication type:

Article

Methadone as First-line Opioid for the Management of Cancer Pain.

Published in:

Oncologist, 2022, v. 27, n. 4, p. 323, doi. 10.1093/oncolo/oyab081

By:

Mercadante, Sebastiano;
Adile, Claudio;
Ferrera, Patrizia;
Pallotti, Maria Caterina;
Ricci, Marianna;
Bonanno, Giuseppe;
Casuccio, Alessandra

Publication type:

Article

Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study.

Published in:

Oncologist, 2022, v. 27, n. 4, p. 253, doi. 10.1093/oncolo/oyab078

By:

Hu, Zhihuang;
Sun, Si;
Zhao, Xinmin;
Yu, Hui;
Wu, Xianghua;
Wang, Jialei;
Chang, Jianhua;
Wang, Huijie

Publication type:

Article

Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of Breast Cancer Subtypes.

Published in:

Oncologist, 2022, v. 27, n. 4, p. e313, doi. 10.1093/oncolo/oyab063

By:

Ni, Yunbi;
Tsang, Julia Y;
Shao, Yan;
Poon, Ivan K;
Tam, Fiona;
Shea, Ka-Ho;
Tse, Gary M

Publication type:

Article

Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601).

Published in:

Oncologist, 2022, v. 27, n. 4, p. 251, doi. 10.1093/oncolo/oyab061

By:

Matsuyama, Jin;
Terazawa, Tetsuji;
Goto, Masahiro;
Kawabata, Ryohei;
Endo, Shunji;
Imano, Motohiro;
Fujita, Shoichiro;
Akamaru, Yusuke;
Taniguchi, Hirokazu;
Tatsumi, Mitsutoshi;
Lee, Sang-Woong;
Kawakami, Hisato;
Kurokawa, Yukinori;
Shimokawa, Toshio;
Sakai, Daisuke;
Kato, Takeshi;
Fujitani, Kazumasa;
Satoh, Taroh

Publication type:

Article

Essentials of Multiomics.

Published in:

Oncologist, 2022, v. 27, n. 4, p. 272, doi. 10.1093/oncolo/oyab048

By:

Marshall, John L;
Peshkin, Beth N;
Yoshino, Takayuki;
Vowinckel, Jakob;
Danielsen, Håvard E;
Melino, Gerry;
Tsamardinos, Ioannis;
Haudenschild, Christian;
Kerr, David J;
Sampaio, Carlos;
Rha, Sun Young;
FitzGerald, Kevin T;
Holland, Eric C;
Gallagher, David;
Garcia-Foncillas, Jesus;
Juhl, Hartmut

Publication type:

Article

Position Statement on the Diagnosis, Treatment, and Response Evaluation to Systemic Therapies of Advanced Neuroendocrine Tumors, With a Special Focus on Radioligand Therapy.

Published in:

Oncologist, 2022, v. 27, n. 4, p. e328, doi. 10.1093/oncolo/oyab041

By:

Capdevila, Jaume;
Grande, Enrique;
García-Carbonero, Rocío;
Simó, Marc;
Olmo-García, Mª Isabel del;
Jiménez-Fonseca, Paula;
Carmona-Bayonas, Alberto;
Pubul, Virginia

Publication type:

Article

Survival According to Primary Tumor Location, Stage, and Treatment Patterns in Locoregional Gastroenteropancreatic High-grade Neuroendocrine Carcinomas.

Published in:

Oncologist, 2022, v. 27, n. 4, p. 299, doi. 10.1093/oncolo/oyab039

By:

Dasari, Arvind;
Shen, Chan;
Devabhaktuni, Anjali;
Nighot, Ruda;
Sorbye, Halfdan

Publication type:

Article

Depression, Anxiety, and Patterns of Mental Health Care Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy.

Published in:

Oncologist, 2022, v. 27, n. 4, p. 314, doi. 10.1093/oncolo/oyab033

By:

Tsao, Phoebe A;
Ross, Ryan D;
Bohnert, Amy S B;
Mukherjee, Bhramar;
Caram, Megan E V

Publication type:

Article

Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial.

Published in:

Oncologist, 2022, v. 27, n. 4, p. 292, doi. 10.1093/oncolo/oyab025

By:

Lipsyc-Sharf, Marla;
Ou, Fang-Shu;
Yurgelun, Matthew B;
Rubinson, Douglas A;
Schrag, Deborah;
Dakhil, Shaker R;
Stella, Philip J;
Weckstein, Douglas J;
Wender, Donald B;
Faggen, Meredith;
Zemla, Tyler J;
Heying, Erica N;
Schuetz, Samantha R;
Noble, Stephanie;
Meyerhardt, Jeffrey A;
Bekaii-Saab, Tanios;
Fuchs, Charles S;
Ng, Kimmie

Publication type:

Article